Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19

NCT04376788 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: exchange blood transfusion from normal donor
BIOLOGICAL: plasma from convalescent patients with COVID-19
DRUG: Methylene Blue 5 MG/ML

Sponsor

Ain Shams University